FDA Inspection 1240823 - POINT Biopharma USA Inc. - June 07, 2024

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns POINT Biopharma USA Inc., with an inspection on June 7, 2024, issued by the Detroit District Office, covering human drugs.

Company: POINT Biopharma USA Inc.
Inspection Date: June 7, 2024
Product Type: Human Drugs
Office: Detroit District Office

Open in Dashboard

ID · efc7aa6b-4ef1-40c9-a20c-e4006bec2eb0